Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (151-160 of 743) with videos related to

Pageof 75
Sort By:
Current Opinion in Oncology|December 28, 2016
Critical aspects to achieve a high-quality melanoma clinicReinhard Dummer, Egle Ramelyte, Mitch Levesque, et al.
Experimental Dermatology|July 10, 2002
Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in miceLucie Heinzerling, Reinhard Dummer, Jovan Pavlovic, et al.
The Journal of Dermatological Treatment|November 8, 2019
Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary centerFlorian Anzengruber, Vanessa Graf, Jürg Hafner, et al.
Human Pathology|April 20, 2007
Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progressionChunlei Zhang, Albena Toulev, Jivko Kamarashev, et al.
Transplantation|March 17, 2004
Treatment of Bowen's disease with imiquimod 5% cream in transplant recipientsBettina M Prinz, Juerg Hafner, Reinhard Dummer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 26, 2022
Adultes Xanthogranulom mit LMNA-NTRK1-Genfusion - ein möglicher ProliferationsfaktorMelike Ak, Egle Ramelyte, Laurence Imhof, et al.
Current Opinion in Oncology|January 17, 2015
Recent advances in primary cutaneous T-cell lymphomaJennifer A DeSimone, Pooja Sodha, Desislava Ignatova, et al.
Experimental Dermatology|November 4, 2014
PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cellsNatalie C Schlegel, Anina von Planta, Daniel S Widmer, et al.
The Journal of Investigative Dermatology|June 4, 2004
GBP-5 splicing variants: New guanylate-binding proteins with tumor-associated expression and antigenicityFriederike Fellenberg, Tanja B Hartmann, Reinhard Dummer, et al.
Cancer|February 13, 2013
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanomaJeffrey S Weber, Reinhard Dummer, Veerle de Pril, et al.
Pageof 75

Showing results (151-160 of 743) with videos related to

Sort By:
Pageof 75
Current Opinion in Oncology|December 28, 2016
Critical aspects to achieve a high-quality melanoma clinicReinhard Dummer, Egle Ramelyte, Mitch Levesque, et al.
Experimental Dermatology|July 10, 2002
Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in miceLucie Heinzerling, Reinhard Dummer, Jovan Pavlovic, et al.
The Journal of Dermatological Treatment|November 8, 2019
Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary centerFlorian Anzengruber, Vanessa Graf, Jürg Hafner, et al.
Human Pathology|April 20, 2007
Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progressionChunlei Zhang, Albena Toulev, Jivko Kamarashev, et al.
Transplantation|March 17, 2004
Treatment of Bowen's disease with imiquimod 5% cream in transplant recipientsBettina M Prinz, Juerg Hafner, Reinhard Dummer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 26, 2022
Adultes Xanthogranulom mit LMNA-NTRK1-Genfusion - ein möglicher ProliferationsfaktorMelike Ak, Egle Ramelyte, Laurence Imhof, et al.
Current Opinion in Oncology|January 17, 2015
Recent advances in primary cutaneous T-cell lymphomaJennifer A DeSimone, Pooja Sodha, Desislava Ignatova, et al.
Experimental Dermatology|November 4, 2014
PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cellsNatalie C Schlegel, Anina von Planta, Daniel S Widmer, et al.
The Journal of Investigative Dermatology|June 4, 2004
GBP-5 splicing variants: New guanylate-binding proteins with tumor-associated expression and antigenicityFriederike Fellenberg, Tanja B Hartmann, Reinhard Dummer, et al.
Cancer|February 13, 2013
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanomaJeffrey S Weber, Reinhard Dummer, Veerle de Pril, et al.
Pageof 75